4,193 followers
Ori. artl: anti-MSLN CAR-Ts that can produce TIGIT-blocking scFv, submitted to, “Emerging Learnings in #CellTherapy: Novel Binding Domains, Universal CAR-T Cells” published. @ChrisHeery @MJFzeta @bhemato @FrontiersIn @FrontOncology #TIGIT #CARTcells https: